| Literature DB >> 20606908 |
Praveen Khilnani1, Sunit Singhi, Rakesh Lodha, Indumathi Santhanam, Anil Sachdev, Krishan Chugh, M Jaishree, Suchitra Ranjit, Bala Ramachandran, Uma Ali, Soonu Udani, Rajiv Uttam, Satish Deopujari.
Abstract
JUSTIFICATION: Pediatric sepsis is a commonly encountered global issue. Existing guidelines for sepsis seem to be applicable to the developed countries, and only few articles are published regarding application of these guidelines in the developing countries, especially in resource-limited countries such as India and Africa. PROCESS: An expert representative panel drawn from all over India, under aegis of Intensive Care Chapter of Indian Academy of Pediatrics (IAP) met to discuss and draw guidelines for clinical practice and feasibility of delivery of care in the early hours in pediatric patient with sepsis, keeping in view unique patient population and limited availability of equipment and resources. Discussion included issues such as sepsis definitions, rapid cardiopulmonary assessment, feasibility of early aggressive fluid therapy, inotropic support, corticosteriod therapy, early endotracheal intubation and use of positive end expiratory pressure/mechanical ventilation, initial empirical antibiotic therapy, glycemic control, and role of immunoglobulin, blood, and blood products.Entities:
Keywords: Pediatric; sepsis; septic shock
Year: 2010 PMID: 20606908 PMCID: PMC2888329 DOI: 10.4103/0972-5229.63029
Source DB: PubMed Journal: Indian J Crit Care Med ISSN: 0972-5229
Figure 1Resources available at different levels of health care facilities in resource-limited countries and feasibility of monitoring and interventions. *Not available universally at all level two facilities
Definitions of sepsis
Systemic Inflammatory Response Syndrome (SIRS) The presence of at least two of the following four criteria, one of which must be abnormal temperature or leukocyte count: Core [oral or rectal] temperature of >38.5 °C or <36°C Tachycardia, in the absence of external stimulus, chronic drugs, or painful stimuli; or otherwise unexplained persistent elevation over a 0.5 h time period or for children <1 year old: bradycardia, in absence of external vagal stimulus, β-blocker drugs, or congenital heart disease; or persistent depression over a 0.5-h time period. Tachypnea for an acute process not related to underlying neuromuscular disease. Leukocyte count elevated or depressed for age [not secondary to chemotherapy-induced leukopenia] or >10% immature neutrophils. Infection A suspected or proven infection caused by any pathogen or a clinical syndrome associated with a high probability of infection. Evidence of infection includes positive findings on clinical examination, imaging, or laboratory tests (e.g., leukocytes in a normally sterile body fluid, perforated viscus, chest radiograph consistent with pneumonia, petechial or purpuric rash, or purpura fulminans) or a positive culture, tissue stain, or polymerase chain reaction test. Sepsis SIRS in the presence of or as a result of suspected or proven infection. Severe Sepsis Sepsis plus one of the following: cardiovascular organ dysfunction OR acute respiratory distress syndrome or two or more other organ dysfunctions. Organ dysfunctions are defined in [ Septic Shock In a child with sepsis presence of: Hypotension [systolic BP <70 mmHg in infant; <70 + 2 × age after 1 year of age] or need for vasoactive drug to maintain BP above fifth centile range [dopamine >5 mcg/kg/min or dobutamine, epinephrine, or norepinephrine at any dose] or Signs of hypoperfusion—any three of the following: decreased pulse volume [weak or absent dorsalis pedis pulse], capillary refilling time >3 s, tachycardia heart rate as defined in [ Sepsis and cardiovascular organ dysfunction as defined in [ Multiple Organ Dysfunction The detection of altered organ functions in the acutely ill patient constitutes multiple organ dysfunction syndrome (MODS; two or more organs involvement). |
Organ dysfunction criteria
| Cardiovascular Dysfunction |
| Hypotension [systolic BP <70 mmHg in infant; <70 +2 × age after 1 year of age] or |
| Need for vasoactive drug to maintain BP above fifth centile range [dopamine >5 mcg/kg/min or dobutamine, epinephrine, or norepinephrine at any dose] or |
| Signs of hypoperfusion–any three of the following: decreased pulse volume [weak or absent dorsalis pedis pulse], capillary refilling time >3 s, tachycardia [heart rate as defined in |
| In early stage, there is an increase in heart rate and poor peripheral perfusion in form of weak pulse and prolonged capillary refill time. Hypotension occurs late, and may lead to precipitous cardiac arrest. |
| Respiratory Dysfunction |
| Proven need for supplemental oxygen(c) or >50% FIO2 to maintain saturation >92% or |
| Need for nonelective mechanical ventilation |
| PaO2/FIO2 <300 in absence of cyanotic heart disease or pre-existing lung disease or |
| PaCO2 >65 torr or 20 mmHg over baseline PaCO2 |
| Neurologic Dysfunction |
| Glasgow Coma Score <11 or |
| Acute change in mental status with a decrease in Glasgow Coma Score >3 points from abnormal baseline |
| Hematologic Dysfunction |
| Platelet count <80000/mm3 or a decline of 50% in platelet count from highest value recorded over the past 3 days [for chronic hematology/oncology patients] or |
| International normalized ratio >2 |
| Renal Dysfunction |
| Serum creatinine >1 mg/dL |
| Hepatic Dysfunction |
| Total bilirubin >4 mg/dL [not applicable for newborn] or, alanine transaminase 2 × upper limit of normal for age |
See Table 2
Acute respiratory distress syndrome must include a PaO2/FIO2 ratio <200 mmHg, bilateral infiltrates, acute onset, and no evidence of left heart failure. Acute lung injury is defined identically except the PaO2/FIO2 ratio must be <300 mmHg.
Proven need assumes oxygen requirement was tested by decreasing flow with subsequent increase in flow if required
In postoperative patients, this requirement can be met if the patient has developed an acute inflammatory or infectious process in the lungs that prevents him or her from being extubated.
Age specific upper and/ or lower limits of heart rate to define tachycardia and bradycardia, respiratory rate to define tachypnea, and systolic blood pressure to define hypotensiona
| Age group | HR (bpm) Mean (range) | RR (breath/min) | Systolic BP, mmHg (range) | MAP-CVP (mmHg) |
|---|---|---|---|---|
| Up to 1 months | 140 [100–190] | >60 | <60 | 55 |
| 2 months to 1 year | 130 [80–180] | >50 | <70 | 60 |
| 1–5 years | 80 [60–140] | >40 | <70+ [2 × age in years] | 65 |
| 6–10 years | 80 [60–130] | >30 | <70+ [2 × age in years] | 65 |
| >10 years | 75 [60–100] | >30 | <90 | 65 |
For heart rate lower values are approximately at 5th percentile and upper values are at 95th percentile for blood pressure, the values are at 5th percentile and for respiratory rate the values are at 5th percentile and for respiratory rate the values are at 95th percentile
ACCM guidelines for evidence-based medicine rating system for strength of recommendation and quality of evidence supporting the references
| Rating System for References |
| (a) Randomized, prospective controlled trial. |
| (b) Nonrandomized, concurrent or historical cohort investigations. |
| (c) Peer-reviewed, state-of-the-art articles, review articles, editorials, or substantial case series. |
| (d) Non-peer-reviewed published opinions, such as textbook statements or official organizational publications. |
| Rating System for Recommendations |
| Level 1: Convincingly justifiable on scientific evidence alone. |
| Level 2: Reasonably justifiable by scientific evidence and strongly supported by expert critical care opinion. |
| Level 3: Adequate scientific evidence is lacking, but widely supported by available data and expert opinion. |
Therapeutic endpoints of resuscitation of septic shock
Normalization of the heart rate Capillary refill of <2sec Well felt dorsalis pedis pulses with no differential between peripheral and central pulses Warm extremities Normal range of systolic pressure and pulse pressure Urine output >1ml/kg/hour Return to baseline mental status tone and posture Normal range respiratory rate Other end-points that have been widely used in adults and may logically apply to children include central venous pressure of 8–12 mmHg |
Sign of pulmonary edema and myocardial dysfunction
| Airway: Airway instability, froth, new-onset cough |
| Breathing: Decreased or increased respiratory rates requiring respiratory support in the absence of neuromuscular diseases, onset of grunt, retractions, abdominal respirations, new rales or wheeze, drop in saturations |
| Circulation: bradycardia, gallop, hypotension, hepatomegaly |
| Disability: Agitation, fighting the mask, combativeness and thirst for water |
| If, any one or a cluster of signs of deterioration are noted during fluid therapy, further fluid administration is discontinued, an appropriate inotrope infusion initiated and intubation is performed. |
Figure 2aIAP intensive care chapter Pediatric sepsis guidelines for resource limited countries